Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Baker

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Carbohydrate Research|February 3, 1994
A synthetic route to 3-C-alkyl (or 3-C-phenyl-) 2,3-dideoxy-D-erythro-pentono-1,4-lactones: intermediates in the synthesis of 2(3H)-furanonesP C Raveendranath, V J Blazis, K Agyei-Aye, et al.
Journal of the American Veterinary Medical Association|December 1, 1994
Multifocal myositis associated with Sarcocystis sp in a horseJ L Traub-Dargatz, J W Schlipf, D E Granstrom, et al.
Journal of Medicinal Chemistry|October 1, 1983
An evaluation of certain chain-extended analogues of 9-beta-D-arabinofuranosyladenine for antiviral and cardiovascular activityD C Baker, R P Crews, T H Haskell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1993
Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidineZ Hao, E E Stowe, G Ahluwalia, et al.
Journal of Pharmaceutical Sciences|November 1, 1985
Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenineW M Shannon, L Westbrook, W I Higuchi, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1997
Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteinsW G Rice, D C Baker, C A Schaeffer, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Carbohydrate Research|February 3, 1994
A synthetic route to 3-C-alkyl (or 3-C-phenyl-) 2,3-dideoxy-D-erythro-pentono-1,4-lactones: intermediates in the synthesis of 2(3H)-furanonesP C Raveendranath, V J Blazis, K Agyei-Aye, et al.
Journal of the American Veterinary Medical Association|December 1, 1994
Multifocal myositis associated with Sarcocystis sp in a horseJ L Traub-Dargatz, J W Schlipf, D E Granstrom, et al.
Journal of Medicinal Chemistry|October 1, 1983
An evaluation of certain chain-extended analogues of 9-beta-D-arabinofuranosyladenine for antiviral and cardiovascular activityD C Baker, R P Crews, T H Haskell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1993
Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidineZ Hao, E E Stowe, G Ahluwalia, et al.
Journal of Pharmaceutical Sciences|November 1, 1985
Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenineW M Shannon, L Westbrook, W I Higuchi, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1997
Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteinsW G Rice, D C Baker, C A Schaeffer, et al.
Pageof 15